Wedgewood Pharmacy Now Compounds Implantable Cisplatin Beads Using Matrix III Under Exclusive License from Royer Animal Health.SWEDESBORO, N.J. -- Wedgewood Pharmacy now is compounding implantable cisplatin cisplatin /cis·plat·in/ (sis´plat-in) DDP; a platinum coordination complex capable of producing inter- and intrastrand DNA crosslinks; used as an antineoplastic. cis·plat·in n. beads using patented Matrix III[TM] drug-delivery technology under an exclusive license from Royer Animal Health. According to Barbara Forney, VMD VMD [L.] Veterina´riae Medici´nae Doc´tor (Doctor of Veterinary Medicine). VMD abbr. Latin Veterinariae Medicinae Doctor (Doctor of Veterinary Medicine) VMD Veterinary Medical Doctor. , a practicing veterinarian veterinarian /vet·er·i·nar·i·an/ (vet?er-i-nar´e-an) a person trained and authorized to practice veterinary medicine and surgery; a doctor of veterinary medicine. vet·er·i·nar·i·an n. and medical writer, cisplatin frequently is prescribed by equine veterinarians as a chemotherapy drug to treat equine skin tumors such as sarcoids, spindle-cell tumors, squamous-cell carcinoma and melanoma. Cisplatin beads using the Matrix III drug-delivery technology are 1.6mg each and dispensed three beads per vial for $75. Each of the spherical beads is about 3mm in diameter. In common veterinary practice, cisplatin is injected directly into tumors in an emulsion of sterile sesame oil. Using the implantable bead-form of cisplatin may reduce the veterinarian's exposure to the highly toxic medication, compared with the injection emulsion, while providing local therapy. George J. Malmberg, R.Ph., F.A.C.A., F.A.C.V.P, the pharmacist president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Wedgewood Pharmacy said: "This new alliance with Royer Animal Health combines that company's proprietary drug delivery technology with our stringent standards for preparing custom-made compounded medicines, which we believe will be of significant value to veterinarians." Dr. Gar Royer, CEO of Royer Animal Health added, "We have enormous confidence in the quality standards at Wedgewood Pharmacy, which is one of the largest compounding pharmacies in the nation. Its procedures comply with the strict USP USP - unique sales point <795> and <797> standards and every compounded preparation undergoes at least five pharmacist-checks before it is dispensed. Wedgewood Pharmacy is known nationally for the consistency of the medications it prepares." ABOUT WEDGEWOOD PHARMACY Wedgewood Pharmacy is one of the largest compounding pharmacies in the United States, providing more than 25,000 prescribers with compounds for their human and veterinary patients. A compounding pharmacy creates customized preparations for individual patients in response to a licensed practitioner's prescription. It is located in Swedesboro NJ and licensed in most states. For additional information about the compounding pharmacy profession, visit the International Academy of Compounding Pharmacists' Web site at ICAPRx.org and CompoundingFacts.org. ABOUT ROYER ANIMAL HEALTH Royer Animal Health, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , is a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Royer Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. , Inc. Since 1997, Royer Biomedical has developed patented technologies that provide medical professionals with localized, controlled release of approved drugs over a broad range of time spans. Royer Biomedical has developed novel drug-delivery technology platforms offering significant advantages over other chemical matrix systems and techniques. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion